Nea Management Company, LLC Crispr Therapeutics Ag Transaction History
Nea Management Company, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Nea Management Company, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Nea Management Company, LLC holds 1,587,854 shares of CRSP stock, worth $89.9 Million. This represents 6.4% of its overall portfolio holdings.
Number of Shares
1,587,854
Previous 1,587,854
-0.0%
Holding current value
$89.9 Million
Previous $54 Million
42.93%
% of portfolio
6.4%
Previous 5.12%
Shares
5 transactions
Others Institutions Holding CRSP
# of Institutions
527Shares Held
68.6MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$576 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$317 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$208 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$185 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$161 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.42B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....